The new technique, described in the current issue of the journal Nanotechnology , was developed by a team led by Dr. Alexandru Biris, assistant professor of applied science and chief scientist at the Nanotechnology Center. Used in cooperation with the University of Arkansas for Medical Sciences, the team successfully killed more than 98 % of cervical cancer cells in the study.

With antibodies or other nanoparticles bioconjugations merging two substances the nanoparticles expects that the cancer cells are found even in advanced cases, including places that were only now considered inoperable. The nanoparticles can also undiagnosed micrometastasis or the spread of cancer cells from the primary site to the secondary tumors too small to be detected clinically. – This research has the understanding of the mechanisms responsible for the effective nanoparticle targeted and eventually the death of cancer cells are renewed, Zharov said.Investigators also show that increased RCAN1-1L rescues cells out to the toxic effects of Huntington disease, a result measures could lead one day new avenues of the treatment, after Davies. ‘We discovery of has real hope to and can even far-reaching implications for a number of other key CAG disease,’said Davies.